Teneligliptin in management of type 2 diabetes mellitus

Teneligliptin is a recently developed oral dipeptidyl peptidase 4 inhibitor indicated for the management of type 2 diabetes mellitus (T2DM) in adults along with diet and exercise. Teneligliptin has been recently available in Japan (Teneria(®)), Argentina (Teneglucon(®)), and India (Tenepure; Teneza)...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diabetes Metab Syndr Obes
Päätekijät: Sharma, Surendra Kumar, Panneerselvam, A, Singh, KP, Parmar, Girish, Gadge, Pradeep, Swami, Onkar C
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2016
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4993264/
https://ncbi.nlm.nih.gov/pubmed/27574456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S106133
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia